Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrave Bison Regulatory News (BBSN)

Share Price Information for Brave Bison (BBSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.525
Bid: 2.50
Ask: 2.55
Change: 0.00 (0.00%)
Spread: 0.05 (2.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2.525
BBSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Incentive Scheme and Grants to Directors

27 Nov 2017 13:00

RNS Number : 6183X
Brave Bison Group PLC
27 November 2017
 

27 November 2017

Brave Bison Group plc ("Brave Bison" or "the Company")

 

Share Incentive Scheme and Grants to Directors

Brave Bison Group plc (AIM: BBSN) announces that the Company has adopted a new long-term share incentive plan, in replacement of the Company's existing share option scheme.

 

RSU Plan

 

The new scheme provides for the grant of restricted stock units ("RSUs") to participants, which subject to vesting, shall entitle the participant to receive new ordinary shares of 0.1p in the Company ("Shares") upon exercise of the RSUs on a one-for-one basis. The total pool of RSUs shall be limited to 12.5 per cent. of the Company's issued ordinary share capital.

 

RSUs shall usually vest over a 3-year period from date of grant, subject only to the continued employment of the participant, and shall expire following a 10-year period. The RSU exercise price shall be determined, at the discretion of the Board, at the time of grant. The Company intends to grant RSUs to existing option-holders in replacement of their options under the Company's previous option scheme.

 

Grants to Directors

 

RSUs have today been granted by the remuneration committee to certain Directors as follows:

 

- Claire Hungate, Chief Executive Officer, has been granted 28,695,461 RSUs. Each RSU may be exercised subject to vesting, at 0.1 pence per Share, and shall vest on a monthly straight-line basis over a 2-year period, starting on 1 August 2017 (being Claire's commencement date with the Company).

 

- Paul Campbell-White, Chief Financial Officer, has been granted 5,739,092 RSUs. Each RSU may be exercised, subject to vesting, at 0.1 pence per Share, and shall vest on a monthly straight-line basis over a 3-year period, starting on 26 October 2017 (being Paul's commencement date with the Company).

 

Related Party Transaction

 

The grants of the RSUs to Claire Hungate and Paul Campbell-White comprise a related party transaction for the purposes of Rule 13 of the AIM Rules for Companies. The independent directors of Brave Bison (being Sir Robin Miller, Paul Marshall and Marc Cranmer), having consulted with the Company's Nominated Adviser, Stockdale Securities, consider that the grants of the RSUs are fair and reasonable insofar as the shareholders of the Company are concerned.

 

 

 

For further information, contact:

 

Brave Bison Group plc Tel: 020 7183 4545

Claire Hungate, Chief Executive Officer

 

Stockdale Securities Tel: 020 7601 6100

Richard Johnson / Andy Crossley

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

About Brave Bison

Brave Bison is an independent digital media and social video broadcaster, proudly working with some of the biggest brands and most followed YouTube and Facebook talent in the world. Clients include P&G, Shell, PGA Tour, Paramount and Google.

Brave Bison makes it simple for content owners, creators, brands, publishers and platforms to unlock the value of online video, whether on a licensed, ad-funded, direct to consumer or paid placement basis.

The business is based in two regions - Europe, with headquarters in London; and APAC, with offices in Singapore.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLDLFLDFFEFBD
Date   Source Headline
22nd Apr 20247:00 amRNSFinal Results
10th Apr 20247:00 amRNSNotice of Results & Investor Presentation
15th Feb 20247:00 amRNSHolding(s) in Company
15th Feb 20247:00 amRNSHolding(s) in Company
23rd Jan 20247:00 amRNSTrading Update
14th Dec 20234:15 pmRNSChange of Registered Office
12th Dec 20232:30 pmRNSGrant of RSU's and Director/PDMR Shareholding
23rd Nov 202311:00 amRNSDirector/PDMR Shareholding
20th Nov 20235:00 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSDirector/PDMR Shareholding
13th Nov 20237:00 amRNSContract Wins & Investor Presentation
24th Oct 20235:15 pmRNSChange of Nominated Adviser and Broker
24th Oct 202312:30 pmRNSDirector/PDMR Shareholding
13th Sep 20237:00 amRNSHalf-year Report
4th Sep 20237:00 amRNSNotice of Results & Investor Presentation
29th Aug 202312:16 pmRNSHolding(s) in Company
15th Aug 202310:00 amRNSHolding(s) in Company
22nd Jun 20234:40 pmRNSHolding(s) in Company
14th Jun 20233:01 pmRNSResult of AGM
14th Jun 20237:00 amRNSAGM Statement
19th May 20237:00 amRNSNotice of AGM
10th May 20238:18 amRNSHolding(s) in Company
27th Apr 20237:00 amRNSFinal Results
19th Apr 20237:00 amRNSNotice of Results & Investor Presentation
10th Mar 20234:58 pmRNSHolding(s) in Company
9th Mar 202311:43 amRNSHolding(s) in Company
21st Feb 20231:34 pmRNSHolding(s) in Company
21st Feb 20231:33 pmRNSHolding(s) in Company
21st Feb 20231:32 pmRNSHolding(s) in Company
21st Feb 20231:30 pmRNSHolding(s) in Company
13th Feb 20235:50 pmRNSHolding(s) in Company
13th Feb 202310:23 amRNSHolding(s) in Company
7th Feb 20237:00 amRNSHolding(s) in Company
6th Feb 20235:28 pmRNSHolding(s) in Company
6th Feb 20235:04 pmRNSDirector/PDMR Shareholding
6th Feb 20231:06 pmRNSHolding(s) in Company
3rd Feb 20237:00 amRNSAcquisition of Social Chain and Vendor Placing
14th Dec 20224:17 pmRNSHolding(s) in Company
7th Dec 202211:17 amRNSHolding(s) in Company
7th Nov 20227:00 amRNSNew Financing Facility
22nd Sep 20227:00 amRNSHalf-year Report
16th Sep 20227:00 amRNSNotice of Interim Results & Investor Presentation
3rd Aug 20223:17 pmRNSHolding(s) in Company
22nd Jul 20221:55 pmRNSHolding(s) in Company
21st Jul 20227:00 amRNSHalf Year Trading Update
11th Jul 20227:00 amRNSDirectorate Change
29th Jun 20225:04 pmRNSResult of AGM
29th Jun 20227:00 amRNSAGM Statement
6th Jun 20227:00 amRNSSignificant Contract Wins
27th May 20224:21 pmRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.